Lam Research Corporation $LRCX Shares Sold by Three Seasons Wealth LLC

Three Seasons Wealth LLC decreased its holdings in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 71.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,854 shares of the semiconductor company’s stock after selling 16,850 shares during the quarter. Three Seasons Wealth LLC’s holdings in Lam Research were worth $2,970,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Valued Retirements Inc. purchased a new position in Lam Research in the second quarter valued at approximately $204,000. Copley Financial Group Inc. purchased a new stake in shares of Lam Research during the 2nd quarter worth approximately $330,000. LifePlan Investment Advisors Inc. purchased a new stake in shares of Lam Research during the 2nd quarter worth approximately $393,000. Knollwood Investment Advisory LLC boosted its holdings in shares of Lam Research by 0.7% in the 2nd quarter. Knollwood Investment Advisory LLC now owns 43,074 shares of the semiconductor company’s stock valued at $18,665,000 after buying an additional 279 shares in the last quarter. Finally, TD Waterhouse Canada Inc. boosted its holdings in shares of Lam Research by 21.8% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 393,729 shares of the semiconductor company’s stock valued at $170,615,000 after buying an additional 70,568 shares in the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Abhijit Talwalkar sold 18,282 shares of the business’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the transaction, the insider owned 42,462 shares in the company, valued at $12,843,056.52. This represents a 10.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 77,782 shares of company stock worth $26,755,370. 0.31% of the stock is currently owned by corporate insiders.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $307.65 on Friday. The stock has a market cap of $384.97 billion, a PE ratio of 53.41, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. The business’s fifty day moving average price is $321.34 and its two-hundred day moving average price is $291.39. Lam Research Corporation has a one year low of $100.68 and a one year high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same quarter in the previous year, the business posted $1.33 earnings per share. The company’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, analysts forecast that Lam Research Corporation will post 9.33 EPS for the current fiscal year.

Lam Research Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is currently 18.06%.

Wall Street Analyst Weigh In

LRCX has been the topic of a number of research analyst reports. HSBC reiterated a “hold” rating and set a $333.00 target price on shares of Lam Research in a research report on Monday, July 27th. B. Riley Financial reduced their target price on shares of Lam Research from $385.00 to $350.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Wells Fargo & Company restated an “overweight” rating and issued a $350.00 price target (down from $450.00) on shares of Lam Research in a research note on Thursday, July 30th. Rothschild & Co Redburn upped their target price on shares of Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $400.00 target price (up from $330.00) on shares of Lam Research in a report on Monday, June 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.97.

View Our Latest Analysis on Lam Research

About Lam Research

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.